Targeting the nasal cavity in rhinitis and sinusitis.

Area of Science:

• Respiratory medicine
• Pharmacology
• Biomedical engineering

Background:

• Aerosol therapy efficacy relies on precise drug targeting within the respiratory tract.
• Innovations in inhaled drug delivery to the lungs have advanced significantly.
• Nasal conditions like rhinitis and sinusitis affect more people than asthma or COPD, yet nasal drug delivery research is limited.

Purpose of the Study:

• To highlight the scarcity of research in nasal aerosol drug delivery.
• To emphasize the importance of understanding dose delivery, distribution, and influencing factors in the nasal cavity.
• To underscore the need for improved drug formulations and inhalation devices for nasal treatments.

Main Methods:

• Review of current knowledge on aerosol therapy and nasal drug delivery challenges.
• Analysis of factors affecting drug deposition in the nasal cavity (anatomy, airflow, disease).
• Identification of knowledge gaps in nasal aerosol delivery systems and formulations.

Main Results:

• Significant innovations exist for lung aerosol delivery, but nasal delivery remains underdeveloped.
• Factors influencing nasal drug targeting, such as anatomy and airflow, are critical but poorly understood.
• Suboptimal delivery techniques lead to reduced efficacy, increased side effects, and drug wastage.

Conclusions:

• There is a critical need for more research into nasal aerosol drug delivery.
• Developing engineered inhalation devices and improved drug formulations is essential for effective rhinitis and sinusitis treatment.
• Understanding drug deposition and performance is key to optimizing nasal aerosol therapies.